reva medical inc - cdi (RVALL:OTC US)

Executive Profile*

Background*

Prof. Dr. Alexandre A. Abizaid, M.D., Ph.D. FACC serves as Chief of Coronary Interventions at Institute Dante Pazzanese de Cardiologia in São Paulo, Brazil. Prof. Abizaid is interested in drug-eluting stents and intravascular ultrasound. He conducted several first-in-man studies testing multiple DES systems and participated very actively in numerous randomized trials and post-marketing registries. Prof. Abizaid serves as Member of Scientific Advisory Board at Sahajanand ... Medical Technologies Pvt. Ltd. and Member of Clinical Advisory Board of MIV Therapeutics Inc. He serves as a Member of Scientific Advisory Board of Conor Medsystems, LLC (alternate name Conor Medsystems Inc.). He serves as a Member of Medical Advisory Board of Angioscore Inc., and Svelte Medical Systems Inc. He serves as Member of the Scientific Advisory Board at REVA Medical Inc. Prof. Abizaid also serves as Member of Advisory Board at Percardia, Inc. He serves as Member of Advisory Board of InspireMD, Inc. He is a key faculty member of CRF and plays an important role as a co-director of TCT. Prof. Abizaid is a member of the Sao Paulo State of Brazil Society of Cardiology and the Latin American Society of Interventional Cardiology, a fellow-trainee of the American College of Cardiology, and certified as a Specialist in Cardiology by the Brazilian Society of Interventional Cardiology. He is a visiting Professor of Medicine at Columbia University Medical Center in New York City. Prof. Abizaid completed Medical school at the Federal University of Juiz de Fora in Brazil, and his fellowship at Washington Hospital Center, in Washington, DC.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
RVALL:US	$0.53 USD	0.00

COMPETITOR COMPENSATION